共 50 条
RETRACTED: HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway (Retracted Article)
被引:21
|作者:
Yang, Guang
[1
]
Zhang, Min
[2
]
Zhao, Yawei
[2
]
Pan, Yue
[2
]
Kan, Mujie
[3
]
Li, Jing
[2
]
He, Kan
[2
]
Zhang, Xuewen
[1
]
机构:
[1] Jilin Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China
[2] Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun, Peoples R China
[3] Jilin Univ, Dept Biochem, Coll Basic Med Sci, Changchun, Peoples R China
来源:
关键词:
EXPRESSION;
MICRORNA-122;
D O I:
10.1371/journal.pone.0230450
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Hepatocellular carcinoma (HCC) is one of the most common human cancers, its prevalence and severity need us to discover novel early diagnostic biomarkers and new therapeutic strategies. MicroRNA-122 is the most abundant microRNA in the liver, and acts as a tumor suppressor and represses HCC development. In our study we showed that HNF-4 alpha and MiR-122 were down-regulated significantly in hepatocellular carcinoma. Over-expression of HNF-4 alpha inhibit hepatocellular carcinoma cells proliferation. And miR-122 is one of the down-stream effector of HNF-4 alpha. Up-regulated miR-122 inhibited hepatocellular carcinoma cells proliferation through regulating ADAM17. Collectively, our results suggested that HNF-4 alpha could inhibit hepatocellular carcinoma proliferation with miR-122 being a downstream target of it. And miR-122 would inhibit hepatocellular carcinoma proliferation by regulating ADAM17 signal pathway.
引用
收藏
页数:10
相关论文